- Details
- Silke Gillessen highlights the International Germ Cell Cancer Collaborative Group (IGCCCG) update model for both seminoma and non-seminoma patients highlighting two recently published articles in the Journal of Clinical Oncology, titled "Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium" and "Survival and New Prognosticat...
|
- Details
- Darren Feldman, MD, and Charles Ryan, MD, discuss multiple topics in this conversation on testicular germ cell tumors ranging from risk factors, developments in treatment, and the global TIGER study. There is limited data for the association of testis cancer with hereditary cancer genes. In this conversation, Daren Feldman highlights developments in treatment for testicular cancer including the in...
|
- Details
- Scott Petinga, a testicular cancer survivor, patient advocate, and entrepreneur, joins Charles Ryan, MD, to provide an update on his work in the field of testicular cancer advocacy. Scott Petinga shares research advances he is a part of at USC as well as different patient resource avenues like social media groups and online forums for newly diagnosed patients and testicular cancer survivors. Biogr...
|
- Details
- The Testicular Cancer Survivorship Clinic, lead by Adult Nurse Practitioner, Mary Dunn is designed to help patients transition from testicular cancer treatment to testicular cancer survivorship. The Testicular Cancer Survivorship Clinic was established in 2008, at the University of North Carolina. Patients who have completed definitive therapy for testicular cancer are transitioned into the clinic...
|
- Details
- The management of stage 2A seminoma has been consistent over the past several years, consisting of either radiotherapy or primary chemotherapy. Cure rates with these approaches are excellent but are also associated with many life years of potential cumulative toxicities. At the 2021 GU ASCO meeting, Dr. Siamak Daneshmand presented a phase 2 study in stage two seminoma, the Surgery In Early Metasta...
|
- Details
- Mike Craycraft, Testicular Cancer Survivor, Clinical Pharmacist and Founder of the Testicular Cancer Society joins Alicia Morgans in this special Testicular Cancer Awareness podcast. Mike shares what drove him to launch the Testicular Cancer Society, a nonprofit raising awareness for testicular cancer, promoting self-examination and helping survivors and caregivers navigate the diagnosis and treat...
|
- Details
- Darren Feldman joins Alicia Morgans to discuss clinical trials and the treatment of testicular cancer. Dr. Feldman provides an overview of the TIGER trial, an international randomized, multicenter open-label phase III trial. The study is an international collaboration with European sites. Collaborators on the study include the National Cancer Institute, the European Organization for Research and T...
|
- Details
- As a testicular cancer survivor and founder of the Center for Advocacy for Cancer of the Testes International (CACTI), Scott Petinga discusses with Charles Ryan, the importance of men to perform monthly self-exams, and seeking medical follow-up with urologists who are experienced in testicular cancer treatment if a suspicious lump or abnormality is suspected. Self-exams are the way most cases of t...
|
